LOROS and University of Leicester seal partnership to benefit teaching, education and research
24th June 2019
LOROS Hospice and the University of Leicester have formalised their partnership with official recognition of LOROS as the University’s affiliated teaching hospice.
The two organisations have worked alongside each other for many years but formal recognition will allow greater collaboration, benefitting training of medical students, education and research development.
With a rapidly increasing ageing population and greater demand for end of life care, the new status of the partnership will play a role in the organisations’ plans to tackle this challenge.
John Knight, CEO of LOROS Hospice said, “We’re very pleased to be entering into this partnership. Through joint working, sharing resources and a greater ability to apply research, our collaboration will have a direct impact on patients. This is a true milestone for our Hospice.
“A key benefit is that teaching of students at LOROS will be directly informed by interactions with real patients, leading to a greater understanding of the care that patients and families need. We hope it will lead to better trained clinicians and improved patient care.”
Professor Philip Baker, Pro-Vice-Chancellor for Life Sciences and Dean of Medicine at the University of Leicester, said: “The University of Leicester is delighted that LOROS is now officially ‘The Affiliated Teaching Hospice of the University of Leicester’.
“The relationship between the University of Leicester and LOROS has gone from strength to strength, building on our long established relationship for teaching students from Leicester Medical School about end of life care (this has been previously been identified as an exemplar of good practice by the GMC).
“Our mutual determination and commitment to ensure that high quality end of life care at LOROS is underpinned by strong and successful academic partnership has led to the establishment of LOROS as a University Teaching Hospice – something I am confident will work for the benefit of patients.”